Cervical Device Contraception-2 (Nanopaz)

NCT00689494 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2008-06-03

No results posted yet for this study

Summary

Measure blood progesterone by using cervical device contraception.

Conditions

  • Healthy

Interventions

OTHER

Nanopaz contraception device

levonorgestrel and levonorgestrel device for cervical contraception-nantechnolgy method

Sponsors & Collaborators

  • Bnai Zion Medical Center

    lead OTHER_GOV

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Month
Max Age
2 Months
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2008-12-31
Completion
2010-05-31

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00689494 on ClinicalTrials.gov